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Abstract.  Embryoid bodies formed from teratocarci- 
noma stem cells differentiate an outer layer consisting 
of parietal and visceral endoderm or of visceral endo- 
derm exclusively. We have previously shown that when 
these embryoid bodies are plated on collagen-coated 
substrates a parietal endoderm-like cell migrates onto 
the substrate,  whereas all of the visceral endoderm re- 
mains associated with the stem cell mass,  suggesting a 
role for substrate contact in parietal endoderm 
differentiation. We now identify fibronectin as the 
migration-promoting component in these cultures, and 
note that laminin and collagen type IV are  10-fold less 
effective at promoting both attachment and endoderm 
outgrowth. The RGDS tetrapeptide (arg-gly-asp-ser) 
from the cell attachment domain of fibronectin can 
specifically block attachment and outgrowth on both 
fibronectin- and laminin-coated substrates.  In addition, 
the involvement of the  140-kD fibronectin receptor is 
demonstrated using an antibody directed against this 
molecule. 
ECENT studies have provided much information con- 
cerning the  molecular nature  of the  cell  substrate 
interactions involved in promoting the migration of 
certain already existing cell types  (19, 30).  However, in- 
stances in which contact with a specific substrate may pro- 
mote the differentiation of a  new cell type, as well as  its 
migration, have not been observed. One of the first instances 
of directed cell migration in the mouse embryo is the migra- 
tion of parietal endoderm around the inner surface of the 
trophectoderm (9). This occurs subsequent to the differentia- 
tion of a layer of primitive endoderm on the side of the inner 
cell mass facing the blastocoele cavity. Although a role for 
the extracellular matrix in the migration and differentiation 
of parietal  endoderm  has  been  proposed  (9),  definitive 
studies have been limited by the fact that these events occur 
subsequent to implantation (26).  For this reason, we have 
turned  to  the  teratocarcinoma  stem  cell  embryoid  body 
system. 
Teratocarcinoma stem cells provide an  excellent model 
system for studying certain events of early mouse embryo- 
genesis (14, 22). We have recently demonstrated that the out- 
growth of parietal endoderm from teratocarcinoma-derived 
embryoid bodies provides an in vitro model system for study- 
ing the comparable event in the embryo (12). Initial studies 
demonstrated  that  considerable  parietal  endoderm  out- 
growth  was  observed  when  appropriate  stage  aggregates 
were plated upon certain substrates even if the aggregates 
contained only visceral endoderm before substrate contact, 
as is the case with retinoic acid-treated F9 aggregates (12, 
14). Interaction with a  migration-promoting substrate was 
sufficient to trigger parietal endoderm differentiation. We re- 
port here that the matrix component responsible for differen- 
tiation and outgrowth in these cultures is fibronectin. Acom- 
parative study indicates that although laminin and type IV 
collagen can also promote endoderm outgrowth, fibronectin 
is significantly more effective. In addition we demonstrate 
that the same hierarchy of matrix component effectiveness is 
observed for attachment of  embryoid bodies. Consistent with 
these observations, the cell attachment tetrapeptide RGDS 
(arg-gly-asp-ser; 3, 24) can inhibit both attachment and out- 
growth of endoderm on fibronectin- and laminin-coated sub- 
strates.  Furthermore, antisera directed against the  140-kD 
fibronectin receptor (4, 5, 25) can block the outgrowth of pa- 
rietal endoderm cells on fibronectin and laminin substrates, 
supporting the contention that laminin as well as fibronectin 
can interact with this receptor in an RGDS-inhibitable fash- 
ion  (15). The in vivo significance of these results  is  dis- 
cussed. 
Materials and Methods 
Cell Culture and Embryoid Body Differentiation 
and Outgrowth 
PSA1 cells were cultured and embryoid bodies formed as previously de- 
scribed (21). Briefly, after 3 d of culture in the absence of feeder cells (day 
3  +  0) the embryoid bodies were pipetted off of the dish and maintained 
in suspension for 4 d (day 3  +  4). The embryoid bodies were then plated 
on acid-soluble calf skin collagen- (Calbiochem-Behring Corp., La Jolla, 
CA) coated coverslips (0.1 mg/ml) as previously described (10), in the pres- 
ence of normal calf serum or fibronectin-free calf serum. Fibronectin was 
removed from the serum by passage over a gelatin-agarose column (Sigma 
Chemical Co.,  St.  Louis,  MO),  as described by Ruoslahti  et al.  (27). 
Fibronectin-coated  coverslips were prepared by incubating the coverslips in 
30  ttg/mi (or the concentration described in the text) of bovine plasma 
fibronectin (Bethesda Research Laboratories, Gaithersberg, MD) or puri- 
fied from bovine plasma by gelatin affinity chromatography, as described 
by Ruoslahti et al. (27), for 1 h. The coverslips were then washed three times 
©  The Rockefeller  University  Press, 0021-9525/87/07/441/8  $2.00 
The Journal  of Cell Biology,  Volume 105, July  1987 441-448  441 :~  100  rr 
o 
D 
~  eo 
-r 
0  40 
0  20 
i  i  i  i  i  i  i  i 
2  4  6  8 
DAYS 
Figure 1. Endoderm outgrowth on collagen in the presence and ab- 
sence of fibronectin. Day 3 +  4 embryoid bodies were plated on 
collagen type I-coated coverslips in the presence of fibronectin- 
containing (solid circles) or fibronectin-free serum (open circles), 
and the extent of endoderm outgrowth determined as described in 
Materials and Methods. 
in PBS. Laminin was the generous gift of Dr. H. Kleinman (Laboratory of 
Developmental Biology, National Institutes of Health, National Institute of 
Dental  Research),  and  collagen  type  IV  was  from Bethesda Research 
Laboratories.  Laminin and collagen IV coverslips were prepared  as de- 
scribed for fibronectin. 
Immunofluorescence 
Cells were fixed and prepared  for indirect immunofluorescence as previ- 
ously described (10).  SSEA-1  monoclonal antibody was the generous girl 
of Dr. Davor Solter (Wistar Institute, Philadelphia, PA) and was used at a 
1:50 dilution. Monospecific rabbit antiserum to mouse laminin (Bethesda 
Research Laboratories) was used at a  1:50 dilution and rabbit antiserum to 
human plasma fibronectin (Bethesda Research Laboratories), or goat an- 
tiserum to rat plasma fibronectin (Calbiochem-Behring Corp.), were used 
at a  hl00 dilution. Fluorescein-conjugated goat anti-mouse IgG, IgA, IgM 
mix and rhodamine-conjugated goat anti-rabbit IgG (all IgG fractions from 
Cappel Laboratories, West Chester, PA) were used at a  1:100 dilution. The 
specificity of these antibodies was determined previously by SDS-PAGE of 
immunoprecipitated material as well as by indirect immunofluorescence 
with a variety of cell types (12). 
Endoderm Outgrowth and Embryoid Body 
Attachment Assays 
The percent endoderm outgrowth was determined as previously described 
(12). Briefly,  the percent of the total attached embryoid bodies containing 
endoderm within the outgrowth was determined based upon morphology 
and SSEA-1  staining (endoderm cells are SSSE-1  negative, whereas stem 
ceils are SSEA-1 positive). 100 outgrowths were counted for each determi- 
nation. For attachment assays embryoid bodies at the designated stage were 
labeled for 4  h in 3.8 laCi/mi [3H]leucine (5 Ci/mmol; New England Nu- 
clear, Boston, MA) in leucine-free medium. They were washed three times 
in PBS and then distributed equally into tissue culture 96-well microtest 
plates (Falcon Labware,  Becton,  Dickinson &  Co.,  Oxnard, CA).  Wells 
were left untreated or coated with collagen type I, fibronectin, laminin, or 
collagen type IV, as described above. Embryoid bodies were allowed to set- 
tle overnight at 37°C. The wells were then washed three times with PBS and 
the attached material was harvested in 1% SDS, transferred into scintillation 
vials, treated with hydrofluor (National Diagnostics, Sommerville, N J), and 
counted in a scintillation counter (Packard Instrument Co., Downer's Grove, 
IL). Each data point was done in triplicate.  Data are expressed as percent 
attachment based on the amount of material added to the well at the begin- 
ning of the assay. Tetrapeptides were from Penninsula Laboratories, Bel- 
mont, CA. Partially purified IgG preparations of normal goat antiserum and 
antiserum directed against the 140-kD fibronectin receptor were generous 
gifts of Dr. P. Brown in Dr. R. Juliano's laboratory. See reference 5a for a 
recent characterization of this antiserum. 
Results 
The Role of  Fibronectin in Endoderm Outgrowth 
We  have  previously  described  the  outgrowth  of parietal 
endoderm-like cells when day 3  +  4 teratocarcinoma em- 
bryoid bodies are plated on substrates precoated with 0.1 
mg/ml type I collagen (12). The identification of the cell type 
contained within the outgrowth was based upon the morphol- 
ogy of these cells as well as their staining pattern by indirect 
immunofluorescence for a number of markers. SSEA-1 anti- 
gen is present on stem cells and not their differentiated deriv- 
atives (29), laminin is made in large amounts by parietal en- 
doderm (6, 16, 20), and alpha-fetoprotein is specific for only 
visceral endoderm cells in these cultures (1). Ceils within 
these outgrowths were SSEA-1 negative, displayed extensive 
laminin-positive areas,  and contained no immunologically 
identifiable alpha-fetoprotein, consistent with their identifi- 
cation as parietal endoderm (12). When fibronectin was re- 
moved from the medium of these cultures by gelatin-affinity 
chromatography of the calf serum, little endoderm outgrowth 
was observed after 3 d (10%) as compared with the outgrowth 
in fibronectin-containing cultures where 70-80% of the out- 
growths contained endoderm by this time (Fig.  1). Fig. 2 a 
shows that endoderm outgrowth obtained in the presence of 
fibronectin consists primarily of large flattened cells that are 
SSEA-1 negative (Fig. 2, a and b). Any outgrowth observed 
(only 10% of the attached embryoid bodies) in the absence 
of fibronectin consisted essentially of cells that were SSEA-1 
positive (Fig. 2, c and d). Fig. 3, a and b demonstrate that 
the outgrowth obtained in the presence of fibronectin is char- 
acterized by extensive laminin-positive areas organized into 
a complex matrix. These data suggest that in the presence of 
fibronectin parietal endoderm outgrowth occurs, whereas in 
its absence stem ceils constitute any outgrowth observed. 
These results suggest that the initial cultures supported endo- 
derm outgrowth due to the well-characterized binding of fi- 
bronectin to collagen (18). To substantiate this conclusion, 
outgrowths cultured on collagen substrates in fibronectin- 
containing medium were stained with anti-fibronectin antise- 
rum.  Uniform areas of fluorescence were observed in cell 
free  regions,  indicating  the  presence  of substrate-bound 
fibronectin (Fig. 3, c and d). Regions onto which endoderm 
cells had migrated appeared clear of fluorescence, suggest- 
ing that these cells had digested the fibronectin (Fig. 3, c and 
d). Note the fluorescence in the upper left corner of Fig. 3 
d due to embryoid body-associated fibronectin. The substrate- 
associated  fibronectin observed in  these  cultures  derived 
from the medium and was not a cell product since regions 
of uniform fluorescence could be visualized when collagen- 
coated substrates were incubated in fibronectin-containing 
medium in the absence of  embryoid bodies (data not shown). 
It is also of interest that no extensive cell-associated deposits 
of fibronectin could be visualized within the endoderm out- 
growth, suggesting the absence of fibronectin synthesis by 
these cells. These results suggest that fibronectin promotes 
the outgrowth of endoderm from embryoid bodies. To more 
directly test the role of fibronectin in endoderm outgrowth, 
embryoid bodies were plated on substrates coated with 30 lxg/ 
ml of bovine plasma fibronectin and cultured in fibronectin- 
free medium for 3  d.  Under these conditions 70%  of the 
outgrowths contained endoderm (Table I). As in previous ex- 
The Journal of Cell Biology, Volume 105,  1987  442 Figure 2. SSEA-1 staining of outgrowths in the presence and absence of fibronectin. Day 3 +  4 embryoid bodies were plated on collagen 
type I coverslips and stained by indirect immunofluorescence for SSEA-1 antigen after 3 d of culture in the presence (a and b) or absence 
(c and d) of fibronectin,  a  and c are phase-contrast  images and b and d are fluorescence images. Bar, 50 pm. 
periments,  78%  of the outgrowths cultured  on collagen in 
fibronectin-containing  serum demonstrated endoderm out- 
growth and only 8 % displayed endoderm outgrowth when 
cultured  in the absence of fibronectin (Table I). The com- 
bined presence of collagen and fibronectin did not increase 
endoderm  outgrowth  beyond  the  level  observed as  fibro- 
nectin  alone  (72%),  indicating  that  fibronectin  is  respon- 
sible for the endoderm outgrowth observed under the initial 
conditions. 
The Role of  Laminin and Collagen ~  IV 
in Endoderm Outgrowth 
The ability of fibronectin to promote the outgrowth of endo- 
derm did not preclude a similar activity for other extracellu- 
Table L Endoderm Outgrowth  from Day 3 4- 4 Embryoid 
Bodies 3 d after Attachment 
Conditions 
Percent 
Medium  endoderm-containing 
Substrate  (± fibron~tin)  outgrowth 
Collagen*  +  78 
Collagen  -  8 
Fibronectin*  -  70 
Fibronectin/collagen  -  72 
* Substrate  coated  with  0.1  mg/ml  collagen as  described  in  Materials  and 
Methods. 
Substrate coated with  30  pg/ml  fibroneetin as  described in  Materials and 
Methods. 
Grabel and Watts Endoderm  Outgrowth and Extracellular Matrix  443 Figure 3. Laminin and fibronectin staining of  outgrowths in the presence of fibronectin. Day 3 + 4 embryoid bodies were plated on collagen 
type I, cultured for 3 d in fibronectin-containing medium, and stained by indirect immunofluorescence for laminin (a and b) or fibronectin 
(c and d). a  and c are phase-contrast  images and b and d are fluorescence images. Bar, 50 gm. 
lar matrix components. Both laminin and collagen type IV 
are synthesized in large amounts by parietal endoderm cells 
and  are  major  components  of  Reicherts'  membrane.  We 
directly tested their ability to support endoderm outgrowth 
under fibronectin-free conditions. Fig. 4 shows that although 
both laminin and collagen type IV can promote endoderm 
outgrowth, they are 10-fold less effective, requiring 40 lag/ml 
to promote 25 % endoderm outgrowth, whereas fibronectin 
demonstrates this level of activity at only 4 Ixg/ml. The addi- 
tion of collagen type IV or laminin to fibronectin-coated sub- 
strates  did  not  increase  the  effectiveness of fibronectin  at 
promoting  outgrowth  (data  not  shown).  This  suggests  no 
cooperative enhancement of outgrowth on mixed substrates. 
Attachment of  Embryoid Bodies to 
Matrix-coated Substrates 
Initial observations suggested that in the absence of fibronec- 
tin there was substantially less substrate attachment of em- 
bryoid bodies.  We therefore examined directly the  attach- 
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Figure 4.  Extent of endoderm outgrowth on fibronectin, laminin, 
and surfaces coated with fibmnectin (solid circles);  laminin (solid 
squares); or collagen  type IV (solid triangles); and the extent  of en- 
doderm outgrowth observed after 3 d of culture. 
ment of  day 3 +  0 and day 3 +  4 embryoid bodies to a variety 
of substrates. These stages were chosen in order to provide 
a  comparison between attachment of stem cell aggregates 
and  aggregates  surrounded  by endoderm;  day 3  +  0  ag- 
gregates are essentially endoderm-free whereas >90 % of the 
3  +  4 aggregates contain endoderm. Embryoid bodies were 
labeled with [3H]leucine for 4 h, and allowed to attach over- 
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Figure 5.  Attachment of embryoid bodies to collagen type I and 
fibronectin substrates. Day 3 + 0 (A) and day 3 + 4 (B) embryoid 
bodies were labeled with [3H]leucine and allowed to attach to tis- 
sue culture plastic, or collagen-coated tissue culture plastic in the 
presence  of fibronectin-containing  serum (open bars),  in the ab- 
sence of fibronectin-containing serum (stippled bars), or in the ab- 
sence of fibronectin-containing serum with fibronectin-coated sub- 
strate (striped bars). Percentage of attachment was determined 16 h 
after plating as described  in Materials and Methods. 
Figure 6. Attachment to fibronectin, laminin, or collagen type IV. 
Day 3 + 4 embryoid bodies were labeled with [+H]leucine and al- 
lowed to attach to surfaces coated with fibronectin (solid circles), 
laminin (solid squares), or collagen type IV (solid triangles) for 
16 h. The percentage of attachment was determined as described in 
Materials and Methods. 
surfaces with no exogenous fibronectin source, with fibro- 
nectin present in the medium, or with fibronectin present as 
a substrate coating (30 Ixg/ml). Day 3  +  0 embryoid bodies 
attached reasonably well to plastic,  regardless of the pres- 
ence or absence of fibronectin, although collagen stimulated 
attachment under certain conditions (Fig. 5 A). Thus, the at- 
tachment of aggregates that contained little or no endoderm 
was fibronectin independent.  In contrast, attachment of day 
3  +  4 embryoid bodies was fibronectin dependent. On plas- 
tic, appreciable attachment occured only when the surface 
was fibronectin coated. On collagen, there was little attach- 
ment unless fibronectin was present either in the medium or 
on the substrate (Fig. 5 B). These results suggest a develop- 
mentally regulated change in the attachment requirements of 
teratocarcinoma cells. The differentiated endoderm cells ac- 
quire a fibronectin dependence not observed with the undif- 
ferentiated stem cells. 
We have also investigated the attachment of day 3 +  4 em- 
bryoid bodies to laminin and type IV collagen. These results 
are shown in Fig. 6. As observed for endoderm outgrowth, 
fibronectin is substantially more active (>10-fold) in promot- 
ing attachment than either of the other matrix proteins. 
Because our observations indicated that fibronectin pro- 
motes attachment as well as outgrowth, it was necessary to 
separate these two effects. It is conceivable, for example, that 
fibronectin selects for the attachment of endoderm-containing 
embryoid bodies and that subsequent outgrowth is perhaps 
matrix independent.  To discriminate between these alterna- 
tives  we  determined  whether  or  not  embryoid bodies  at- 
tached in the absence of fibronectin contained an endoderm 
outer layer. 50 % of the aggregates attached 16 h after plating 
contained endoderm, although only 10 % of them supported 
subsequent  endoderm  outgrowth.  This  indicates  that  al- 
though a significant number of the attached aggregates con- 
tained endoderm, most did not generate endoderm outgrowth 
in the absence of fibronectin.  This observation, as well as 
some additional experiments described below, suggest that 
fibronectin is involved in specifically promoting outgrowth 
as well as attachment. 
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Figure 7. Inhibition of attachment by RGDS tetrapeptide. Day 3 + 
4 embryoid bodies were labeled with [3H]leucine and allowed to 
attach to surfaces coated with 10 ~tg/ml fibmnectin for 16 h in the 
presence of RGDS (arg-gly-asp-ser) (solid circles); or VGSE (val- 
gly-ser-glu) (open circles). The percentage of  attachment was deter- 
mined as described in Materials and Methods. 
purifed IgG preparation characterized in reference 5a) to the 
140-kD  receptor was added to cultures of day 3  +  4  em- 
bryoid bodies which had attached overnight to  substrates 
coated with  10  gg/ml  fibronectin.  The cultures were ob- 
served 24 h later. Fig. 8 a and b show that this antiserum (500 
gg/mi) could block endoderm outgrowth, whereas equiva- 
lent concentrations of normal goat serum (partially purified 
IgG preparation) had no effect. In addition,  an antiserum 
against cell CAM 120/80 (7) had no effect on outgrowth (data 
not shown). This effect  was not due to selective toxicity, since 
the treated embryoid bodies remained viable, based on try- 
pan blue exclusion, 24 h after antibody addition. Numerous 
rounded cells appear in Fig. 8, a  and c due to the fact that 
any cells that become dissociated from the aggregate are 
prevented from substrate attachment by the presence of the 
antiserum. When similar experiments were performed using 
laminin-coated substrates  (20  and  80  gg/ml),  the  results 
shown in  Fig.  8,  c  and d  were obtained.  Outgrowth was 
blocked by the anti-140 kD antibody and not by normal goat 
serum. These data suggest that the outgrowth of endoderm 
on either fibronectin- or laminin-coated substrates involves 
the 140-kD fibronectin receptor. They also support the con- 
tention that fibronectin supports  outgrowth as well as  at- 
tachment. 
Effect of the l~bronectin  Cell-attachment Tetrapeptide 
and Antibody to the l~bronectin  Receptor on 
Embryoid Body Attachment and Endoderm Outgrowth 
A tetrapeptide sequence, RGDS (arg-gly-asp-ser), that can 
inhibit the attachment of cells to fibronectin as well as other 
matrix proteins, has recently been identified (3, 15, 24). This 
sequence is present in a number of molecules that mediate 
adherence and is contained within the cell attachment do- 
main of fibronectin. We compared the effect of RGDS and 
a control tetrapeptide, VGSE (val-gly-ser-glu), on the attach- 
ment of day 3  +  4 embryoid bodies. RGDS inhibits attach- 
ment by 50% at 0.5 mM, whereas the control tetrapeptide 
shows no effect at 1.0 mM (Fig. 7). This level of inhibition 
is comparable to that observed for normal rat kidney cell 
attachment to  fibronectin (50%  at  1 mM;  reference 24). 
When a  similar experiment was performed using laminin- 
coated substrates (20 ~tg/ml) there was a slight but reproduc- 
ible inhibition of attachment by RGDS relative to the control 
tetrapeptide, suggesting that this specific sequence can inter- 
fere with laminin-based interactions as well (data not shown). 
To determine if the tetrapeptide could block outgrowth as 
well as attachment, day 3 +  4 embryoid bodies were allowed 
to attach to fibronectin- (10 ~tg/ml) coated substrates over- 
night, and RGDS or VGSE was then added and the percent 
endoderm outgrowth determined after 24 h. Although inhi- 
bition  of endoderm outgrowth was  consistently observed 
with RGDS and not with VGSE, the extent was minimal and 
variable (10-30% at 0.5 mM). Since the amount of tetrapep- 
tide available was limited, we used antibody directed against 
the 140-kD fibronectin receptor to substantiate the involve- 
ment  of  fibronectin-cell  interactions  in  endoderm  out- 
growth. 
Recent evidence indicates that the cell attachment site of 
fibronectin binds to a 140-kD cell surface fibronectin recep- 
tor that has been identified and characterized by a number 
of different laboratories (4, 5, 25). An antiserum (partially 
Discussion 
A  clear picture of the  molecular interactions involved in 
morphogenesis is now emerging from the combination of re- 
cent information obtained from in vitro studies identifying 
the molecules responsible for cell adhesion and directed cell 
migration and studies that focus on the in vivo localization 
of these molecules during embryogenesis (8,  13,  30).  The 
identification of molecules that promote cell migration dur- 
ing mammalian embryogenesis is difficult since these events 
take place subsequent to implantation (26). Teratocarcinoma 
stem cells have proven invaluable in identifying the mole- 
cules that mediate intercellular adhesion (7, 11,  17, 33). We 
demonstrate here that teratocarcinoma embryoid bodies can 
be used to study the substrate specificity of endoderm out- 
growth. We have previously shown that when embryoid bod- 
ies are attached to collagen-coated substrates, parietal en- 
doderm cells  migrate  out  onto  the  substrate  even under 
conditions in which no parietal endoderm was initially pres- 
ent. We show here that the outgrowth in these cultures was 
due to the binding of serum fibronectin to the collagen sub- 
strate.  Endoderm  outgrowth  is  observed on  fibronectin- 
coated  surfaces  in  fibronectin-free medium.  Indirect  im- 
munofluorescence staining  with anti-fibronectin antiserum 
suggested that the parietal endoderm cells themselves may 
not be capable of synthesizing and/or accumulating fibronec- 
tin when associated with a fibronectin substrate.  Although 
this observation is difficult to follow up in these cultures be- 
cause of  the presence of  the embryoid bodies that are actively 
synthesizing and secreting fibronectin, it has been proposed 
that PYS cells, a parietal endoderm cell line, do not actively 
synthesize fibronectin (32). This point is of interest in view 
of the well-documented observation that neural crest cells 
adhere and migrate on fibronectin surfaces in vitro and do 
not synthesize the protein (23). 
In  contrast,  parietal  endoderm  cells  synthesize  large 
amounts of laminin (6) and type IV collagen (2), although 
The Journal of Cell Biology, Volume  105,  1987  446 Figure 8. The effect of antibody to the 140-kD fibronectin receptor and normal goat serum on endoderm outgrowth. Day 3 + 4 embryoid 
bodies were allowed to attach to surfaces coated with 10 Ixg/ml fibronectin (a and b), or 20 ltg/ml laminin (c and d) for 16 h. 500 ~tg/ml 
of partially purified IgG directed against the  140-kD fibronectin receptor (a and c) or 500 l~g/ml of partially purified normal goat IgG 
(b and d) were added and the cultures observed after 24 h. Bar, 50 Ixm. 
both of  these matrix glycoproteins are each 10-fold less effec- 
tive than fibronectin at promoting endoderm outgrowth. The 
attachment  of  endoderm-containing  embryoid  bodies  is 
fibronectin dependent, and, again, both laminin and collagen 
type  IV  are  10-fold  less  effective.  The  observation  that 
fibronectin-free cultures contain a substantial number of at- 
tached embryoid bodies that contain an outer layer of endo- 
derrn and yet are incapable of generating endoderm-specific 
outgrowth is consistent with the conclusion that fibronectin 
is important for both outgrowth and attachment. The similar 
dose-response curve obtained with the three matrix glyco- 
proteins for both attachment and outgrowth suggests that the 
same  cell  surface  receptor(s) may mediate  both of these 
processes. In this regard it is of interest that the RGDS se- 
quence can inhibit attachment to both fibronectin and lami- 
nin substrates and that antibody against the 140-kD fibronec- 
tin receptor is effective at blocking endoderm outgrowth on 
either fibronectin or laminin substrates, suggesting that the 
140-kD receptor may be involved in interactions with a vari- 
ety of matrix molecules. These observations are particularly 
interesting in light of  those made by Horwitz et al. suggesting 
that laminin could interact with this fibronectin receptor in 
an RGDS-inhibitable fashion (15). It is also clear from recent 
studies that the RGD sequence is present in many proteins 
that  are  associated  with  cell  attachment  events,  and  that 
numerous receptors capable of recognizing this  sequence 
may be present at the cell surface (28). 
A role for cell-cell and cell-matrix interactions in direct- 
ing the differentiation of parietal endoderm from primitive 
endoderm cells has been proposed (9). Our previous findings 
suggested that interaction with a migration-promoting sub- 
strate may initiate the differentiation as well as the migration 
of parietal endoderm (12). The data presented here indicate 
that fibronectin can provide such a substrate in vitro and that 
interaction with the 140-kD fibronectin receptor is also in- 
volved. In support of the relevance of these findings to the 
in vivo process, fibronectin has been localized to the inner 
surface of  the trophectoderm at 4 d in the mouse embryo, just 
before the migration of parietal endoderm cells (31). The use 
of teratocarcinoma embryoid bodies promises to facilitate a 
molecular analysis of the events controlling migration and 
differentiation during early mammalian embryogenesis. 
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